The treatment of Ta-T1 bladder cancer in the era of worldwide BCG shortage
Minerva Urol Nefrol
.
2016 Apr;68(2):192-3.
Epub 2016 Mar 16.
Authors
Maurizio Brausi
1
,
Simone Morselli
Affiliation
1
Department of Urology, A.S.L. Modena, Bernardino Ramazzini Hospital, Carpi, Italy - simone.morselli.89@gmail.com.
PMID:
26982374
No abstract available
MeSH terms
Administration, Intravesical
BCG Vaccine / supply & distribution*
BCG Vaccine / therapeutic use*
Carcinoma, Transitional Cell / therapy*
Humans
Urinary Bladder Neoplasms / therapy*
Urologists
Substances
BCG Vaccine